Most respiratory virus activity remains low overall across the EU/EEA. Influenza has returned to inter-seasonal levels. COVID 19 circulation is also very low. RSV activity is elevated but decreasing. Peak levels having passed in most countries.
An agency of the European Union
Frequent searches:
Most respiratory virus activity remains low overall across the EU/EEA. Influenza has returned to inter-seasonal levels. COVID 19 circulation is also very low. RSV activity is elevated but decreasing. Peak levels having passed in most countries.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 April 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, measles, zika, and chikungunya.
Communicable disease threats report, 12-18 April 2026, Week 16
English (1.3 MB - PDF)
Social media card on vaccination protecting families and strengthens communities.
Social media card on vaccination against HPV.
Social media card on vaccination - not just for children.
Social media card - for over 50 years, vaccination has improved lives in Europe.
Social media card on vaccination throughput our lives.
Social media card on vaccination against hepatitis B
Social media card on vaccination when planning a pregnancy
Social media card on vaccination of vulnerable people.
Social media card on vaccination of children
ECDC supports external quality assessment schemes to strengthen capability and use of reliable laboratory methodologies and ensure comparability of data for EU-level surveillance purposes.
In this episode, we speak with microbiologists Theresa Enkirch and Maximilian Riess who explain how wastewater surveillance works and why it is becoming increasingly valuable for public health.
European Immunization Week (EIW) is an initiative led by the World Health Organization (WHO) to raise awareness about the vital role immunisation plays to prevent diseases and protect life. This year’s EIW runs from 19-25 April.
Overview of annual planned procurement procedures at ECDC.
The call for abstracts for the ESCAIDE 2026 is open until 18 May.
Since the previous update on 2 March 2026, and as of 30 March 2026, no new MERS cases have been reported by WHO or national health authorities.
A worldwide epidemiological summary of the countries most affected by cholera.
Since 25 February 2026 and as of 30 March 2026, 17 723 new cholera cases, including 212 new deaths, have been reported worldwide.
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
Since April 2012, and as of 30 March 2026, a total of 2 647 MERS cases, including 959 deaths, have been reported by health authorities worldwide.
This reporting protocol is for the 2026 data call for antimicrobial resistance (AMR) surveillance data, collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for 2025.
European Antimicrobial Resistance Surveillance Network (EARS-Net) surveillance data for 2025
English (1.93 MB - PDF)